Form 4: Treace Medical Concepts Director, Deepti Jain, Reports Stock Transactions

Director Deepti Jain reports acquisition of restricted stock units and disposal of common stock.

Summary

• Deepti Jain, a director at Treace Medical Concepts, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 20, 2025, Jain acquired 23,917 restricted stock units (RSUs).
• Jain also disposed of 70,243 shares of common stock.
• Following these transactions, Jain beneficially owns 70,243 shares, including 23,917 RSUs.
• The RSUs will vest 100% on the earlier of May 20, 2026, or the date of the 2026 annual meeting of stockholders, contingent upon continued service to the Issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.

Future Outlook

The RSUs will vest 100% on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Director, Treace Medical Concepts, TMCI, Stock Transaction, Deepti Jain